More Other Countries IP Communications Stories

Health Robotics, a supplier of life-critical intra-venous medication robots, has signed five exclusive distribution agreements for its CytoCare, i.v.STATION, and i.v.SOFT technologies in four Eastern European countries.

According to the company, CytoCare is the first and only robotic system proven to work anywhere in the world for the safe and sterile preparation of hazardous intravenous admixtures, including chemotherapy, monoclonal antibody therapy and gene therapy. With 56 installations currently under contract in 17 countries, CytoCare has long proven its unmatched flexibility to adapt to diverse pharmacy workflows and proprietary IV consumables in 4 continents.

I.v.STATION represents a revolutionary approach in the quest for safe, accurate, efficient, cost-effective, and ready-to-administer intravenous patient doses. I.v.STATION offers reduction of IV medication errors, USP 797 and GMP compliance, compatibility with 75-plus different syringe and IV Bags brands/sizes, reduction of IV waste, and significant labor savings all within a scalable, cost-effective, distributed, and fail-safe architecture.

i.v.SOFT constitutes an ideal complement to CytoCare and i.v.STATION both as a means to back-up robotic devices and to direct excess IV Admixture production demand and non-standard IV consumables towards Laminar Airflow Hoods equipped with Health Robotics' life-critical i.v.SOFT software

“As previously announced last year, Health Robotics will continue to aggressively optimize its worldwide distribution channel strategies by rewarding high-performance distributors while making changes where appropriate if prior marketing channel strategies do not yield the success that they rightly expect from their unique products,” said Gaspar DeViedma, Health Robotics’ executive vice president, in a statement.

DeViedma is also very pleased to reward B. Braun Medical s.r.o [Czech Republic] with a contract for CytoCare's exclusive rights as a direct result of its three "live" installations in 2009-10 (General University Hospital of Prague, Ceske Budejovice Hospital, and Zlin Regional Hospital), which is a great accomplishment in such a short period of time, considering the size of Czech Republic's healthcare industry and the budget crisis during the last two years.